2010
DOI: 10.1016/j.biopsych.2009.09.033
|View full text |Cite
|
Sign up to set email alerts
|

A Meta-Analysis of Cytokines in Major Depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

135
2,619
26
61

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 3,970 publications
(2,938 citation statements)
references
References 211 publications
135
2,619
26
61
Order By: Relevance
“…As reported elsewhere, in cellular assays of potency to block tryptophan-to-KYN conversion, the in vitro 50 % inhibitory concentration (IC 50 ) on murine IDO1 was 50 nM (Liu et al, 2010). For murine IDO2 IC 50 was >5000 nM and for 9 human TDO2 it was >10000 nM; therefore, in vitro selectivity of IDOInh for IDO1 relative to IDO2 was >100 and relative to TDO2 was >200 (Liu et al, 2010). In an in-house cellular assay, IC 50 on murine IDO1 was 390 nM.…”
Section: Indoleamine 23-dioxygenase Inhibitorsupporting
confidence: 60%
See 2 more Smart Citations
“…As reported elsewhere, in cellular assays of potency to block tryptophan-to-KYN conversion, the in vitro 50 % inhibitory concentration (IC 50 ) on murine IDO1 was 50 nM (Liu et al, 2010). For murine IDO2 IC 50 was >5000 nM and for 9 human TDO2 it was >10000 nM; therefore, in vitro selectivity of IDOInh for IDO1 relative to IDO2 was >100 and relative to TDO2 was >200 (Liu et al, 2010). In an in-house cellular assay, IC 50 on murine IDO1 was 390 nM.…”
Section: Indoleamine 23-dioxygenase Inhibitorsupporting
confidence: 60%
“…A small-molecule, potent (both human and murine) and selective inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1) (hereafter IDOInh) (see (Liu et al, 2010;Yue et al, 2009) and (Cathomas et al, 2015)) was used. As reported elsewhere, in cellular assays of potency to block tryptophan-to-KYN conversion, the in vitro 50 % inhibitory concentration (IC 50 ) on murine IDO1 was 50 nM (Liu et al, 2010).…”
Section: Indoleamine 23-dioxygenase Inhibitormentioning
confidence: 99%
See 1 more Smart Citation
“…Increases of the circulating cytokines interleukin (IL)-6 and tumor necrosis factor alpha (TNF), their soluble receptors, and the acute phase protein, C-reactive protein (CRP), have been reported (Dowlati et al, 2010); for review see: (Felger and Lotrich, 2013;Miller et al, 2009). Moreover, gene expression profiling conducted on post-mortem brain tissue samples from the frontal cortex of patients with MDD shows an upregulated expression of cytokines including eg IL-1, IL-18, IL-8, IL-12, lymphotoxin alpha and interferon (IFN)- (Shelton et al, 2011).…”
mentioning
confidence: 99%
“…Later studies demonstrated an important role for TNFα in mediating systemic inflammation based on its ability to mediate lethal endotoxin poisoning and lethal septic shock [2123]. The production of this cytokine is deregulated in variety of human diseases including malignancies [24], Alzheimer’s disease [25], major depression [26] and inflammatory bowel disease (IBD) [27]. TNFα production is tightly controlled by both transcriptional and post-transcriptional mechanisms.…”
Section: Introductionmentioning
confidence: 99%